Sebastian J, Cai l, Williamson D, Foushee B, Kam-Morgan L, Eisenberg MT. Identification and characterization of two novel sequence variants in the Thrombopoietin Receptor (MPL) gene using data from 8700 JAK-2 V617F negative patients. Poster presented at the 2016 Association for Molecular Pathology (AMP) Annual Meeting; November 10, 2016. Charlotte, NC. [abstract] J Mol Diagn. 2016 Nov; 18(6):955. doi: 10.1016/S1525-1578(16)30176-3
Shakoor A, Esterberg E, Acharya NR. Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm. 2014 Apr;22(2):96-101. doi: 10.3109/09273948.2013.812222
Brown TM, Horblyuk RV, Grotzinger KM, Matzdorff AC, Pashos CL. Patient-reported treatment burden of chronic immune thrombocytopenia therapies. BMC Blood Disord. 2012 Mar 1;12(1):2.
Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb;20(1):18-26. doi: 10.3109/09273948.2011.633205.
Bray JW, Davis KL, Graver L, Schroeder D, Buck JA, Dilonardo J, Vandivort R. Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 states. J Behav Health Serv Res. 2005 Jan 1;32(3):282-93.